ADINE EDWARDS: Open Payments
NPI 1538702162 · SPRINGFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,578 in 172 payments from 19 companies in 2025. Trend: 2023 $2,699 · 2024 $3,316 · 2025 $3,578
Food & beverage: $3,479Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 55 | $883 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $454 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $286 |
| Janssen Biotech, Inc. | 9 | $273 |
| Madrigal Pharmaceuticals | 6 | $222 |
| QOL Medical, LLC | 8 | $218 |
| Ipsen Biopharmaceuticals, Inc | 8 | $211 |
| Gilead Sciences, Inc. | 6 | $204 |
| GENZYME CORPORATION | 7 | $137 |
| PFIZER INC. | 5 | $133 |
Products named: XIFAXAN, TREMFYA, SKYRIZI, RINVOQ, REZDIFFRA, Sucraid, LINZESS, IQIRVO.
Industry payments across OH — which companies pay providers there.
